Literature DB >> 17495351

Molecular cytogenetic characterization of eight small supernumerary marker chromosomes originating from chromosomes 2, 4, 8, 18, and 21 in three patients.

Joanna Pietrzak1, Kristin Mrasek, Ewa Obersztyn, Pawel Stankiewicz, Nadezda Kosyakova, Anja Weise, Sau Wai Cheung, Wei Wen Cai, Ferdinand von Eggeling, Tadeusz Mazurczak, Ewa Bocian, Thomas Liehr.   

Abstract

Small supernumerary marker chromosomes (sSMCs) are a morphologically heterogeneous group of additional structurally abnormal chromosomes that cannot be identified unambiguously by conventional banding techniques alone. Molecular cytogenetic methods enable detailed characterization of sSMCs; however, in many cases interpretation of their clinical significance is problematic. The aim of our study was to characterize precisely sSMCs identified in three patients with dysmorphic features, psychomotor retardation and multiple congenital anomalies. We also attempted to correlate the patients' genotypes with phenotypes by inclusion of data from the literature. The sSMCs were initially detected by G-banding analysis in peripheral blood lymphocytes in these patients and were subsequently characterized using multicolor fluorescence in situ hybridization (M-FISH), (sub)centromere-specific multicolor FISH (cenM-FISH, subcenM-FISH), and multicolor banding (MCB) techniques. Additionally, the sSMCs in two patients were also studied by hybridization to whole-genome bacterial artificial chromosome (BAC) arrays (array-CGH) to map the breakpoints on a single BAC clone level. In all three patients, the chromosome origin, structure, and euchromatin content of the sSMCs were determined. In patient RS, only a neocentric r(2)(q35q36) was identified. It is a second neocentric sSMC(2) in the literature and the first marker chromosome derived from the terminal part of 2q. In the other two patients, two sSMCs were found, as M-FISH detected additional sSMCs that could not be characterized in G-banding analysis. In patient MK, each of four cell lines contained der(4)(:p11.1-->q12:) accompanied by a sSMC(18): r(18)(:p11.2-->q11.1::p11.2-->q11.1:), inv dup(18)(:p11.1-->q11.1::q11.1-->p11.1:), or der(18) (:p11.2-->q11.1::q11.1-->p11.1:). In patient NP, with clinical features of trisomy 8p, three sSMCs were characterized: r(8)(:p12-->q11.1::q11.1-->p21:) der(8) (:p11.22-->q11.1::q11.1-->p21::p21-->p11.22:) and der(21)(:p11.1-->q21.3:). The BAC array results confirmed the molecular cytogenetic results and refined the breakpoints to the single BAC clone resolution. However, the complex mosaic structure of the marker chromosomes derived from chromosomes 8 and 18 could only be identified by molecular cytogenetic methods. This study confirms the usefulness of multicolor FISH combined with whole-genome arrays for comprehensive analyses of marker chromosomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17495351     DOI: 10.1007/BF03194675

Source DB:  PubMed          Journal:  J Appl Genet        ISSN: 1234-1983            Impact factor:   3.240


  48 in total

1.  AcroM fluorescent in situ hybridization analyses of marker chromosomes.

Authors:  S Langer; C Fauth; M Rocchi; J Murken; M R Speicher
Journal:  Hum Genet       Date:  2001-08       Impact factor: 4.132

2.  Degenerate oligonucleotide-primed PCR: general amplification of target DNA by a single degenerate primer.

Authors:  H Telenius; N P Carter; C E Bebb; M Nordenskjöld; B A Ponder; A Tunnacliffe
Journal:  Genomics       Date:  1992-07       Impact factor: 5.736

3.  [Characterization of marker chromosomes using molecular cytogenetic methods in patients with mental retardation and congenital malformations].

Authors:  Ewa Bocian; Beata Nowakowska; Ewa Obersztyn; Katarzyna Borg; Ilse Chudoba; Ewa Kostyk; Anna Kruczek; Jacek Pietrzyk; Tadeusz Mazurczak
Journal:  Med Wieku Rozwoj       Date:  2006 Jan-Mar

Review 4.  Inv dup(15) supernumerary marker chromosomes.

Authors:  T Webb
Journal:  J Med Genet       Date:  1994-08       Impact factor: 6.318

5.  Clinical findings in patients with marker chromosomes identified by fluorescence in situ hybridization.

Authors:  R Plattner; N A Heerema; P N Howard-Peebles; J H Miles; S Soukup; C G Palmer
Journal:  Hum Genet       Date:  1993-07       Impact factor: 4.132

6.  Forty-two supernumerary marker chromosomes (SMCs) in 43,273 prenatal samples: chromosomal distribution, clinical findings, and UPD studies.

Authors:  Oliver Bartsch; Anne Loitzsch; Peter Kozlowski; Marie-Luise Mazauric; Gabriele Hickmann
Journal:  Eur J Hum Genet       Date:  2005-11       Impact factor: 4.246

7.  Supernumerary marker chromosomes (SMC) and uniparental disomy (UPD): coincidence or consequence?

Authors:  D Kotzot
Journal:  J Med Genet       Date:  2002-10       Impact factor: 6.318

Review 8.  Small supernumerary marker chromosomes (sSMC) in humans.

Authors:  T Liehr; U Claussen; H Starke
Journal:  Cytogenet Genome Res       Date:  2004       Impact factor: 1.636

Review 9.  Muellerian aplasia associated with ring chromosome 8p12q12 mosaicism.

Authors:  Judith Loeffler; Elisabeth Soelder; Martin Erdel; Barbara Utermann; Andreas Janecke; Hans-Christoph Duba; Gerd Utermann
Journal:  Am J Med Genet A       Date:  2003-01-30       Impact factor: 2.802

10.  Mechanisms of small ring formation suggested by the molecular characterization of two small accessory ring chromosomes derived from chromosome 4.

Authors:  Y Y Fang; H J Eyre; S K Bohlander; A Estop; E McPherson; T Träger; O Riess; D F Callen
Journal:  Am J Hum Genet       Date:  1995-11       Impact factor: 11.025

View more
  8 in total

Review 1.  Neocentromeres: new insights into centromere structure, disease development, and karyotype evolution.

Authors:  Owen J Marshall; Anderly C Chueh; Lee H Wong; K H Andy Choo
Journal:  Am J Hum Genet       Date:  2008-02       Impact factor: 11.025

2.  Mechanisms and consequences of small supernumerary marker chromosomes: from Barbara McClintock to modern genetic-counseling issues.

Authors:  Erin L Baldwin; Lorraine F May; April N Justice; Christa L Martin; David H Ledbetter
Journal:  Am J Hum Genet       Date:  2008-02       Impact factor: 11.025

3.  Molecular definition of high-resolution multicolor banding probes: first within the human DNA sequence anchored FISH banding probe set.

Authors:  Anja Weise; Kristin Mrasek; Ina Fickelscher; Uwe Claussen; Sau Wai Cheung; Wei Wen Cai; Thomas Liehr; Nadezda Kosyakova
Journal:  J Histochem Cytochem       Date:  2008-02-05       Impact factor: 2.479

4.  Tetrasomy 18p in a male dysmorphic child in southeast Turkey.

Authors:  Mahmut Balkan; Hatun Duran; Turgay Budak
Journal:  J Genet       Date:  2009-12       Impact factor: 1.166

Review 5.  Chromosome 5 derived small supernumerary marker: towards a genotype/phenotype correlation of proximal chromosome 5 imbalances.

Authors:  Joana Barbosa Melo; Liesbeth Backx; Joris R Vermeesch; Heloisa G Santos; Ana C Sousa; Nadezda Kosyakova; Anja Weise; Ferdinand von Eggeling; Thomas Liehr; Isabel Marques Carreira
Journal:  J Appl Genet       Date:  2011-03-25       Impact factor: 3.240

6.  Partial trisomy 2q33.3-q37.3 in a patient with an inverted duplicated neocentric marker chromosome.

Authors:  Ruiyu Ma; Ying Peng; Yanghui Zhang; Yan Xia; Guizhi Tang; Jiazhen Chang; Ruolan Guo; Baoheng Gui; Yanru Huang; Chen Chen; Desheng Liang; Lingqian Wu
Journal:  Mol Cytogenet       Date:  2015-02-06       Impact factor: 2.009

7.  Molecular characterization of 20 small supernumerary marker chromosome cases using array comparative genomic hybridization and fluorescence in situ hybridization.

Authors:  Mingran Sun; Han Zhang; Guiying Li; Carrie J Guy; Xianfu Wang; Xianglan Lu; Fangchao Gong; Jiyun Lee; Susan Hassed; Shibo Li
Journal:  Sci Rep       Date:  2017-09-04       Impact factor: 4.379

8.  Unexpected structural complexity of supernumerary marker chromosomes characterized by microarray comparative genomic hybridization.

Authors:  Karen D Tsuchiya; Kent E Opheim; Mark C Hannibal; Anne V Hing; Ian A Glass; Michael L Raff; Thomas Norwood; Beth A Torchia
Journal:  Mol Cytogenet       Date:  2008-04-21       Impact factor: 2.009

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.